Clinical Trials Logo

Smoking clinical trials

View clinical trials related to Smoking.

Filter by:

NCT ID: NCT05473585 Completed - Smoking Clinical Trials

Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2

Start date: October 12, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate how limiting the nicotine content in regular cigarettes affects choices for regular cigarette and e-cigarette products. Eligible participants will be of legal age to purchase tobacco products and regularly use both e-cigarettes and regular cigarettes.

NCT ID: NCT05471349 Completed - Smoking Cessation Clinical Trials

Message Testing in Older Adult Smokers

Start date: July 12, 2022
Phase: N/A
Study type: Interventional

This study is examining different messages to motivate older smokers to quit smoking. Participants will be current smokers, between the ages of 50-80 years old, who do not have a history of cognitive impairment or dementia. Participants can expect to take part in a one-time 30 minute online survey.

NCT ID: NCT05448976 Completed - Smoking Clinical Trials

Potential Effect for the Smoking on Periodontitis From the Perspective of Arginine Metabolites

Start date: August 12, 2021
Phase: N/A
Study type: Interventional

Arginine metabolites are amino acids that are associated with vascular tone regulation and the level of inflammation, with critical roles in the synthesis of NO. Our aim was to determine the ADMA, SDMA, L-NMMA, L-arginine, L-homoarginine and IL-6 levels in saliva and serum samples from periodontitis patients and periodontally healthy individuals and to assess the levels of these compounds according to smoking status and compare these levels to those of healthy individuals.

NCT ID: NCT05385055 Completed - Inflammation Clinical Trials

Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking

Start date: June 13, 2022
Phase:
Study type: Observational

This is a cross-sectional 3-group study with subjects enrolled and matched by region (Asia, Europe), age, sex, and average daily product consumption over the last 2 years as self-reported. The study will be conducted as a multi-center and multi-regional study, to demonstrate beneficial effects of switching from cigarettes to THS.

NCT ID: NCT05374707 Completed - Smoking Clinical Trials

The Effect of Motivational Interviewing Technique on Smoking Urge and Smoking Cessation Success in Teachers

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

Background: Smoking, which remains one of the biggest public health threats that the world faces and has reached epidemic proportions, continues to cause more than eight million deaths on average per year worldwide. The aim of the study was to evaluate the effect of motivational interviewing technique on the smoking urge and the success of smoking cessation in teachers. Methods: This was an experimental (randomized controlled) study where motivational interviews were conducted with the individuals in the experimental group. The sample of the study was chosen from the teachers, who met the inclusion criteria, in the secondary schools in the central districts of Manisa. The study was completed with 30 smokers in the experimental group and 31 smokers in the control group. Questionnaire on Smoking Urges, Smoking Cessation Success Prediction Scale and Sociodemographic Data Form were used as data collecting tools. Chi-square test, Mann-Whitney U test, Wilcoxon test, t-test and regression analysis were used to analyse the data.

NCT ID: NCT05363254 Completed - Smoking Clinical Trials

CSD200902: Assessment of Indoor Air Quality for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Environmental Testing Chamber

Start date: May 23, 2022
Phase: N/A
Study type: Interventional

This is a single-center, open-label, parallel-cohort study to measure and compare the levels of selected secondhand smoke (SHS) constituents of a heated tobacco product (HTP) against combustible cigarettes (CC) after ad libitum smoking sessions by generally healthy smokers in an environmental testing chamber (ETC). Evaluation of SHS constituents detected during non-smoking sessions will be performed as a control.

NCT ID: NCT05362318 Completed - Lung Cancer Clinical Trials

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

Start date: June 7, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.

NCT ID: NCT05339659 Completed - Smoking Cessation Clinical Trials

Randomized Pilot Study of a mHealth App for Ambivalent Smokers Living With HIV

Start date: June 2, 2022
Phase: N/A
Study type: Interventional

This pilot study will assess the acceptability and feasibility a novel mHealth app designed for smokers who are ambivalent about quitting and have been diagnosed with HIV.

NCT ID: NCT05317195 Completed - Smoking Clinical Trials

Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

This is a single-center, randomized, controlled, open-label, cross-over study in healthy smoking subjects to investigate the nicotine pharmacokinetic (PK) profiles of 4 variants of Nicotine pouch 1.0 compared to marketed Velo - Nicotine Pouch (NP) and Zyn-NP. In addition, pharmacodynamic (PD) effects will be evaluated to provide further insights on Nicotine pouch 1.0 product acceptance and abuse liability. The study will be conducted with 3 periods and 6 sequences in a Williams design (cross-over).

NCT ID: NCT05313100 Completed - Smoking Clinical Trials

Sugammadex and Smoker's Neuromuscular Block

Start date: April 2012
Phase: Phase 4
Study type: Interventional

We compared the durations of antagonizing and of the severity of effect of sugammadex used in antagonizing the rocuronium in smoker and non-smoker total 40 patients with using Train of Four(TOF) neuromuscular monitorization.